Technegas (Cyclomedica Asia Pacific) is a versatile yet straightforward system for producing
high-quality 99mTc-based ventilation studies using a carbon-based nanoparticle. Because …

Technegas is a carbon-based nanoparticle developed in Australia in 1984 and has been in
widespread clinical use, including SPECT imaging, since 1986. Although 81mKr offers the …

Technegas, a carbon-coated Tc-99m nanoparticulate aerosol invented by Burch at the
Australian National University in 1984, was introduced to the medical community in 1986 …

Pulmonary embolism demands rapid and accurate diagnosis. And ventilation imaging has
greatly improved the diagnostic accuracy of pulmonary embolism in addition to perfusion …

Technegas was developed in Australia as an imaging radioaerosol in the late 1980s and is
now commercialized by Cyclomedica, Pty Ltd. for diagnosing pulmonary embolism (PE) …

Technegas, a newly developed ultra-fine dry dispersion of Tc-99m labeled carbon with a
particle size of approximately 5 nm to 20 nm, possesses the properties for lung ventilation …

The demand for high-quality ventilation imaging of the lungs has resulted in the advent of
Technegas, which has proven its superiority to the more conventional agents in a number of …

Technegas, an aerosol generator recently devised in Australia, produces aerosol
particulates called'technegas' which have characteristics of both an aerosol and a gas. The …

Lung scintigraphy is primarily used to diagnose pulmonary embolism. Ventilation imaging is
often performed using 99mTc-DTPA or Technegas, an ultrafine dispersion of 99mTc-labeled …

The image quality obtained with technetium-99mC aerosol (Technegas) was evaluated and
compared with that obtained with 99m Tc-phytate aerosol generated by a jet nebulizer. Fifty …